Search

everythinglearnresearchcommunity

for

Search:↓

Topical finasteride with EGCG or TA improves drug release and dermal uptake, potentially treating hair loss effectively.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

Sorafenib after liver surgery may increase survival for some liver cancer patients.

Created microspheres show potential for safe and effective use in prostate artery embolization.

Cold caps and certain drugs may help prevent or reduce hair loss from chemotherapy, but more research is needed.

SCDSFs from zebrafish embryos are beneficial for treating cancer, regenerating tissues, and improving conditions like psoriasis and alopecia.

Low ferritin, vitamin D deficiency, and thyroid problems may contribute to hair loss in some hospital patients in Western Saudi Arabia.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.